Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues
Completed clinical trial analyzing cell count, viability, and immunogenicity of discarded newly diagnosed glioblastoma tissue or solid tumor…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma [Phase 1]
This clinical trial update describes a Phase 1 study of a neoantigen-based personalized DNA vaccine for newly diagnosed unmethylated gliobla…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluates azeliragon in combination with chemoradiotherapy for newly diagnosed glioblastoma, sponsored by Cantex …
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: INtraoperative photoDYnamic Therapy of GliOblastoma [NA]
A completed clinical trial evaluating intraoperative photodynamic therapy for glioblastoma.
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma [Phase 2]
Phase 2 clinical trial evaluating simultaneous integrated boost using FDOPA PET guidance for glioblastoma in partially- or non-operated adul…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma [Phase 1]
This is a Phase 1 clinical trial evaluating memory-enriched T cells for recurrent or refractory Grade III-IV glioma, including glioblastoma …
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study [Phase 2]
Mayo Clinic sponsors a Phase 2 trial (SAGA) evaluating short-course radiotherapy for glioblastoma; the study is currently active but not rec…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma [Phase 1]
Phase 1 trial evaluating tumor hypoxia and proliferation in high-grade glioma has been suspended. Sponsor: Weill Medical College of Cornell …
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Leica Microsystems Sponsored PMCF Study to Collect and Confirm Clinical Data on the Performance of the GLOW400 Device When Used in Accordance With Its Intended Use
Leica Microsystems has initiated a post-market clinical follow-up study to collect data on the performance of the GLOW400 device when used a…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma [Phase 2]
This clinical trial update reports a Phase 2 study evaluating a neoantigen-pulsed autologous dendritic cell vaccine in combination with temo…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM [Phase 1, Phase 2]
The document reports that a Phase 1/2 clinical trial evaluating Exablate-enabled disruption of the blood-brain barrier with Carboplatin for …
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Evaluation of UCPVax Vaccine +/- Pembrolizumab Combined With Standard Treatment as Adjuvant Therapy in Patients With Unmethylated MGMT Glioblastoma [Phase 2]
Phase 2 clinical trial evaluating UCPVax vaccine with or without pembrolizumab added to standard therapy for unmethylated MGMT glioblastoma;…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma [Phase 1]
Phase 1 trial evaluating mycophenolate mofetil in combination with standard of care for glioblastoma; study status is ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma [Phase 2]
Phase 2 clinical trial update from University Hospital Tuebingen investigating protective VEGF inhibition for isotoxic dose escalation in gl…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Niraparib/TTFields in GBM [Phase 2]
Phase 2 trial evaluating niraparib in combination with TTFields for glioblastoma is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG [Phase 2]
Phase 2 pediatric trial evaluating indoximod with chemotherapy and radiation for relapsed brain tumors or newly diagnosed diffuse intrinsic …
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas [EARLY_Phase 1]
A terminated early-phase 1 trial evaluated repurposed ketoconazole for glioblastoma, reporting on its neuro-pharmacological properties.
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma [Phase 2]
This is a Phase 2 clinical trial evaluating nivolumab with radiation therapy and bevacizumab for recurrent MGMT-methylated glioblastoma; the…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid [Phase 2]
Phase 2 trial update examining how platelet levels influence outcomes in glioblastoma patients treated with temozolomide.
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma [Phase 1]
Phase 1 dose-escalation trial of re-irradiation in good-prognosis recurrent glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy [Phase 4]
A Phase 4 clinical trial sponsored by Mayo Clinic comparing telehealth and in-person assessments in glioma patients undergoing oral chemothe…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations [Phase 2]
Phase 2 trial of pemigatinib in previously treated glioblastoma and other primary CNS tumors with FGFR1-3 alterations was terminated; result…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma [Phase 1]
A Phase 1 study evaluating tumor treating fields with hypofractionated chemoradiotherapy in newly diagnosed glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Supramarginal Resection in Glioblastoma Guided by Artificial Intelligence [NA]
Clinical trial update reports completion of a study evaluating artificial intelligence-guided supramarginal resection for glioblastoma.
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors. [Phase 1]
A Phase I study of [177Lu]Lu-FF58 in patients with advanced solid tumors was terminated. The sponsor was Novartis Pharmaceuticals, and the t…